Zacks Investment Research
26 May 2026, 22:46 UTC · 2h ago
Source · https://www.zacks.com/stock/news/2927122/medtronic-mdt-stock-drops-despite-market-gains-important-facts-to-note?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2927122
Read source
Search tags
Story key points
4 claims · impact-rated
Medtronic is currently assigned a Zacks Rank of #4 (Sell). — A 'Sell' rating from a major research provider suggests a bearish outlook on the stock's near-term performance.
-0.40Medtronic's upcoming earnings report on June 3, 2026, is expected to show a 3.7% year-over-year decline in EPS to $1.56. — Anticipated earnings contraction generally exerts downward pressure on a stock price.
-0.30Medtronic's consensus revenue estimate for the upcoming quarter is $9.66 billion, an 8.26% increase year-over-year. — Top-line growth is a positive signal, though partially offset by the expected decline in earnings per share.
+0.20Medtronic's Forward P/E ratio of 12.94 is at a discount compared to the industry average of 18.7. — A lower relative valuation may attract value investors, though it can also reflect fundamental weaknesses.
Impact vectors
1 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Ticker attribution
Model heads
The company has a Zacks Rank of #4 (Sell), shares are lagging the S&P 500, and EPS is projected to fall compared to the previous year.
No ticker relationship head found.
